Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $2.6000 (0.58%) ($2.6000 - $2.6000) on Tue. May. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.78% (three month average) | RSI | 24 | Latest Price | $2.6000(0.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -4.6% a day on average for past five trading days. | Weekly Trend | AUTL declines -8.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) IWO(94%) SKYY(84%) IWM(81%) BOTZ(88%) ARKK(87%) | Factors Impacting AUTL price | AUTL will decline at least -1.89% in a week (0% probabilities). SHY(-95%) BND(-62%) XLP(-50%) SPLV(-27%) IGOV(-26%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.89% (StdDev 3.78%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-19.44(-847.69%) | Resistance Level | $3.34 | 5 Day Moving Average | $2.9(-10.34%) | 10 Day Moving Average | $3.04(-14.47%) | 20 Day Moving Average | $3.34(-22.16%) | To recent high | -44.4% | To recent low | 0.6% | Market Cap | $136m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |